Mr. Gruener is a co-founder of Alta, and was also a Partner at Burr, Egan, Deleage & Co. He served as the Chief Executive Officer at Nanōmix from 2008 to 2013 and has more than two decades of experience in the fields of software development, systems engineering and corporate development. In 1982, he founded Virtual Microsystems, a successful communications software company that was later merged with a larger corporation. Garrett also founded Ask Jeeves, now Ask.Com, a leading Internet search engine which is now part of IAC. Garrett specializes in information technology and is on the board of directors of nCircle Network Security and Xelerated. He earned a Masters Degree from the University of California, Berkeley and a Bachelor of Science from the University of California, San Diego, both in Political Science with a focus on technology policy.
President and CEO
Mr. Ludvigson is a financial and operating executive, and entrepreneur, with over 35 years of international experience in life sciences and technology companies including IDEC Pharmaceuticals, Matrix Pharmaceutical, Nanogen, and MIPS Computer Systems. He has over 20 years of Life Science experience including more than 15 years in the diagnostics arena and has led numerous new product efforts from concept to market launch. Mr. Ludvigson has concluded many successful strategic transactions including multiple acquisitions, corporate partnerships, technology and intellectual property licensing agreements, and OEM relationships and his financing experience includes venture capital, corporate, mezzanine, lease, bank credit line, LBO, IPO and secondary public sources. Mr. Ludvigson holds both a BA and MAS from the University of Illinois.
Vice President of Finance & Chief Financial Officer
Mr. Jung has 20 years of financial and healthcare experience that includes roles as Chief Business Development Officer at Alameda Hospital and Chief Financial Officer at Cal eConnect. He has served in management level financial positions with Kaiser Permanente, Blue Shield of California, United Behavioral Health, and McKesson HBOC. Mr. Jung holds an MPH from the Harvard School of Public Health, an MBA from the Johnson School of Management at Cornell University and a Post-Graduate diploma from the London School of Economics.
Vice President, Operations
Mr. Gyorke has an extensive medical device commercialization background, having served in executive and engineering roles for over 25 years. Most recently he was Vice President of Development & Operations at Farallon Medical, an in vitro diagnostic startup company. Prior to that, he was the VP of Operations with Cholestech Corp. overseeing the Operations and scale up of disposable device production. Before these positions, he held Engineering Management roles with Boston Scientific Target, manufacturing their Class 3 neuro-access devices, and embolic products. David is very familiar in the application of rapid-cycle-time methodologies in bringing medical device products to market in a cost effective and ISO 13485/14971 compliant manner.
Vice President of Engineering
Ms. Lavagnino has over 25 years of experience in developing software and integrated hardware systems. As Senior Director of Engineering at Cognex Corporation, Ms. Lavagnino was responsible for the successful launch of highly integrated manufacturing and inspection systems. Prior to Cognex Ms Lavagnino held the position of Senior Software Engineer at Isys Controls. The author of numerous patents, Sherrill graduated from Smith College.
Vice President, Development
Dr. Wray has over 25 years of experience in the diagnostics industry including roles with PerkinElmer, Celera, Ventana Medical, and Abbott Laboratories. His experience includes product development of instrument, reagent, and software systems involving molecular diagnostics, immunoassays, and mass spectrometry, as both LDTs and IVDs. He has also been responsible for CE, FDA, and CFDA registrations. Dr. Wray holds a Ph.D. in Genetics from the University of Texas (Austin), an M.S. in Health and Medical Science from University of California (Berkeley), and was an NIH postdoctoral fellow at University of Pennsylvania.